News

Reduced competition, shortages, and unaffordable options in healthcare are symptoms of middlemen running amok. These middlemen are the...

Unfortunately for Americans, consolidation in the healthcare industry has neither reduced costs nor improved clinical outcomes. 340B...

Bipartisan Respondents Strongly Favor Policies that Require PBMs to Provide Value and Lower Drug Costs Washington, DC – With pharmacy...

While calls to “start over again” and “blow up the whole model” seasoned today’s meeting of the Senate Finance Committee investigating...

Mark Blum, Managing Director of the PBM Accountability Project, issued a statement about the Senate Commerce Committee progress on the...

Eli Lilly & Co. is cutting the list prices for Humalog and Humulin, its two biggest-selling insulin products by 70%. The price cuts will...

House Republicans have launched an investigation into the companies that manage drug benefits, dialing up the scrutiny of the middlemen...

The Senate Commerce Committee held a hearing on Feb. 16 to discuss how pharmacy benefit managers (PBMs) impact patients and community...

Pharmacy benefit managers (PBMs) -- middlemen between pharmacies, health insurers, and drug companies -- are responsible for driving up...

The drumbeat of calls to enact reforms to pharmaceutical middlemen is growing louder after years of largely unsuccessful attempts by...

Pharmacy benefit managers (PBMs) came under some harsh attacks and critiques today at a Senate hearing about legislation that would add...

The Senate Commerce Committee today held a hearing in which members on both sides of the aisle raised questions about the practices of...

Doug Dority, Chairman of the Board of the PBM Accountability Project penned a letter to Senators Maria Cantwell and Chuck Grassley in...

Senators pilloried the lack of transparency from pharmacy benefit managers during a hearing Thursday, as lawmakers hope to pass reforms...

It's never pleasant for your industry when senators are publicly musing at a hearing about whether your companies should exist, but...

When you think of industries dominated by a few powerful players (*cough* tech *cough*), the pharmacy benefit manager (PBM) industry...

Mark Cuban made scathing, profanity-laced remarks about pharmacy benefit managers (PBMs) and heaped praised on drug manufacturers...

Medicaid managed-care giant Centene has agreed to pay California $215 million to settle a drug-pricing scandal related to one that was...

Doug Dority, Chairman of the Board of the PBM Accountability Project penned a letter to members of the Biden Administration in response...

President Biden’s State of the Union Address hammered home the point that drug prices must come down. He reminded viewers that he and his...

The politics and policies of high drug prices have been swirling around for years. But recently, attention has shifted to PBMs, which...

Many patients seeking better drug treatments are being rejected by their insurance companies. The reason: Patients must first “fail” at...

Pharmacy benefit managers (PBMs) may be Congress’ next target for high prescription drug prices. There is evidence that PBMs may be...